Table 3.
Structure and Activities of Analogs 22a
Compound | R | PAR4-AP PAC-1 IC50 (μM)b (pIC50±SEM) | PAR4-AP % Max PAC-1a | PARI %Maxc |
---|---|---|---|---|
7 | 0.18 (6.74±0.06) | 0.32 | 98 | |
22a |
![]() |
0.32 (6.49±0.03) | 0.66 | 84 |
22b |
![]() |
2.4 (5.61±0.13) | 5.1 | 80 |
22c |
![]() |
0.16 (6.79±0.04) | −1.2 | 92 |
22d |
![]() |
0.63 (6.2±0.09) | 1.3 | 81 |
22e |
![]() |
2.1 (5.67±0.10) | 11 | 90 |
(5.67±0.10) | ||||
22f |
![]() |
0.24 (6.61±0.05) | 0.32 | 92 |
22g |
![]() |
1.3 (5.88±0.13) | 4.2 | 85 |
22h |
![]() |
1.2 (5.92±0.11) | 2.84 | 76 |
Values indicate the percentage of max PAC-1 binding after PAR4-AP stimulation of human platelets.
Average of three independent determinations.
Values indicate the percentage PAR1 activity in the presence of 10 μM compound.